Patisiran
Category: Neurological DisordersPatisiran Overview
Patisiran, sold under the brand name Onpattro, is a medication for the treatment of polyneuropathy in people with hereditary transthyretin-mediated amyloidosis. Hereditary transthyretin-mediated amyloidosis is a fatal rare disease that is estimated to affect 50,000 people worldwide.[1] It is the first small interfering RNA-based drug approved by the U.S. Food and Drug Administration (FDA) and the first drug approved by the FDA to treat this condition.[1] It is ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Patisiran
Recent Patisiran Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Patisiran
- Injection: 2mg/ml
- Solution: 10mg/5ml (2mg/ml)
Other drugs which contain Patisiran or a similar ingredient: (1 result)
- ONPATTRO Patisiran